Diagnostic and therapeutic relevance of non-coding RNAs in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a systematic review
Journal of the Korean Medical Association · 10.10.2025 · 68 (10) · 682-698
DOI: 10.5124/jkma.25.0028 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of the Korean Medical Association, erschienen am 10.10.2025. Verfasst von Qais Ahmad Naseer und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science and Technology.
Abstract (Originalsprache)
Purpose
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide, driving an urgent need for innovative biomarkers and therapeutic strategies. This systematic review discusses the roles of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in the progression of MASLD. It also examines their potential in treating its advanced form, metabolic dysfunction-associated steatohepatitis (MASH).
Methods
A comprehensive search of PubMed, Embase, Web of Science, and Cochrane Library databases (2010–2023) identified 134 studies meeting the inclusion criteria from an initial pool of 2,180 articles. Among these, 96 studies focused on miRNAs (miR-34a and miR-122), 38 on lncRNAs, and 11 on circRNAs. Data extraction was performed independently by three investigators, and discrepancies were resolved through discussion to ensure the accuracy and reliability of the findings.
Results
Key non-coding RNAs (ncRNAs) such as miR-34a, NEAT1, MEG3, MALAT1, and circRNA SCAR demonstrated significant diagnostic and therapeutic potential due to their dynamic expression patterns associated with MASLD progression. miR-34a and MALAT1 were linked to lipid metabolism and inflammation, while NEAT1 and MEG3 influenced fibrosis and insulin resistance. CircRNA SCAR was downregulated, underscoring its role in regulating oxidative stress. Incorporating multiple miRNAs improved diagnostic accuracy, emphasizing their clinical relevance.
Conclusion
The findings underscore the promise of circulating ncRNAs as non-invasive biomarkers and therapeutic targets for MASLD and MASH. However, large-cohort studies and mechanistic investigations are necessary to validate their clinical application and accelerate their integration into patient care.
Förderung
- Ministry of Science and Technology
Zitieren
APA
Naseer, Q. A., Xuexian, C., Yimai, D., Khan, M. A., & Chen, S. (2025). Diagnostic and therapeutic relevance of non-coding RNAs in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a systematic review. Journal of the Korean Medical Association, 68(10), 682-698. https://doi.org/10.5124/jkma.25.0028
Vancouver
Naseer QA, Xuexian C, Yimai D, Khan MA, Chen S. Diagnostic and therapeutic relevance of non-coding RNAs in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a systematic review. Journal of the Korean Medical Association. 2025;68(10):682-698. doi:10.5124/jkma.25.0028
BibTeX
@article{Naseer2025,
author = {Naseer, Qais Ahmad and Xuexian, Cao and Yimai, Deng and Khan, Muhammad Ajmal and Chen, Shengxia},
title = {Diagnostic and therapeutic relevance of non-coding RNAs in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a systematic review},
journal = {Journal of the Korean Medical Association},
year = {2025},
volume = {68},
number = {10},
pages = {682--698},
doi = {10.5124/jkma.25.0028}
}
EUVIMED